Using ultraviolet light, a Fresno scientist says he can kill pathogens in raw milk while preserving its immuno-benefits.

Moderna has announced the FDA approval of a new, lower-dose messenger RNA (mRNA) vaccine against COVID-19, called mNEXSPIKE (mRNA-1283) (1). The product joins Moderna’s original COVID vaccine, ...

“The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,” CEO Stephane Bancel said in the statemen ...

May 30, 2025 -- The FDA has approved a new treatment for dry eye disease (DED) after studies showed it can help stimulate natural tear production as early as the first day of use. The new drug ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. The authorization was confirmed by digital health tech company ...

May 27 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said the U.S. Food and Drug Administration has approved its meningococcal vaccine for use in infants as young as six weeks ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...

The FDA's new voucher program will dramatically reduce drug review times for companies meeting national health priorities.

Up to 4x more patients on Tryptyr had a ≥10mm tear increase vs. placebo at Day 14 in COMET-2 and COMET-3 (p<0.0001). Tryptyr showed statistically significant tear production as early as Day 1 ...

The new treatment device, Lenire, has been recently approved by the Food and Drug Administration (FDA) but is not covered by insurance. The device and treatment introduces electrical currents ...